tirzepatide glp 1 and gip Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control body weight reduction GLP-1/GIP dual agonist tirzepatide normalizes

The enhanced GI effects may cause temporary water weight shifts, while the stronger appetite suppression can lead to reduced food intake that shows up as an artificially steep drop on the scale

Lyophilized tirzepatide vials Lyophilized, or freeze-dried, tirzepatide represents the most stable form available

Key Specifications Telehealth with prescription : Yes Accepts insurance : No Consultation fee : $0 (included in package) Membership fee : No Medications available : Ozempic, Mounjaro, compounded semaglutide, compounded tirzepatide, metformin, and MIC + B12 injection Pros and Cons Pros They have licensed clinicians overseeing the process

In patients treated with semaglutide, weight loss continued over 65 weeks and was sustained for up to 4 years

Distributing protein intake throughout the day (20-30 grams per meal) optimizes muscle protein synthesis